American Century Companies Inc Trans Medics Group, Inc. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$70.86 - $89.93 $15.1 Million - $19.1 Million	-212,474 Reduced 41.82%	295,606 $21.9 Million
Q4 2023 Feb 13, 2024	BUY	$36.74 - $81.08 $18.7 Million - $41.2 Million	508,080 New	508,080 $40.1 Million
Q3 2023 Nov 13, 2023	BUY	$53.47 - $96.07 $19 Million - $34.2 Million	355,755 Added 271.15%	486,956 $26.7 Million
Q2 2023 Aug 14, 2023	SELL	$66.23 - $88.73 $7.59 Million - $10.2 Million	-114,632 Reduced 46.63%	131,201 $11 Million
Q1 2023 May 11, 2023	SELL	$53.63 - $82.33 $7.24 Million - $11.1 Million	-134,949 Reduced 35.44%	245,833 $18.6 Million
Q4 2022 Feb 13, 2023	BUY	$39.08 - $64.29 $14.9 Million - $24.5 Million	380,782 New	380,782 $23.5 Million

388

31.4M

465K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.31B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.